Evidence map›Paper›PMID 26797093›Full record

ArticleChinese journal of cancer2016

Segmental ureteroileal conduit resection for the treatment of distal upper urinary tract recurrence of bladder cancer following cystectomy.

Shu-Xiong Zeng, Xin Lu, Wei-Dong Xu, Zhen-Sheng Zhang, Hai-Hang Li, Ying-Hao Sun, Chuan-Liang Xu

Open access · goldAbstract readCase Reports
In one paragraph

Article in Chinese journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shu-Xiong ZengDepartment of Urology, Changhai Hospital, Second Military Medical University, Shanghai, P. R. China. zengshuxiong@126.com.
Xin LuDepartment of Urology, Changhai Hospital, Second Military Medical University, Shanghai, P. R. China. luxin_smmu@163.com.
Wei-Dong XuDepartment of Urology, Changhai Hospital, Second Military Medical University, Shanghai, P. R. China. ayxwd@qq.com.
Zhen-Sheng ZhangDepartment of Urology, Changhai Hospital, Second Military Medical University, Shanghai, P. R. China. 13761178177@163.com.
Hai-Hang LiDepartment of Burns, Changhai Hospital, Second Military Medical University, Shanghai, P. R. China. drxuchuanliang@126.com.
Ying-Hao SunDepartment of Urology, Changhai Hospital, Second Military Medical University, Shanghai, P. R. China. sunyh@medmail.com.cn.
Chuan-Liang XuDepartment of Urology, Changhai Hospital, Second Military Medical University, Shanghai, P. R. China. chuanliang_xu@126.com.
Second Military Medical University · CNChanghai Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Segmental ureterectomy is less invasive than radical nephroureterectomy and results in nephron preservation and satisfactory tumor control. This study was to determine the feasibility of segmental ureteroileal conduit resection (SUICR) for patients with distal upper urinary tract recurrence of bladder cancer following radical cystectomy. Four patients with high-grade distal upper urinary tract recurrence underwent SUICR 15-108 months after radical cystectomy. The surgical technique details of SUICR, operative results, and follow-up outcomes are reported. The median operation time was 280 min, and estimated blood loss was less than 100 mL. One patient suffered from ileus 5 days after surgery and was managed conservatively. Histopathologic evaluation showed high-grade stages pTa-pT1 diseases for these patients, and ureteral margins were all negative. No patient suffered from tumor recurrence, with a median follow-up of 39 months. SUICR preserved the ipsilateral renal unit and conformed to oncological principles during surgery. The oncological outcome was satisfactory for these properly selected patients. This technique provides a valid alternative to nephroureterectomy for patients with imperative indications and high-grade upper urinary tract recurrence of bladder cancer following radical cystectomy.

Indexed as

AgedCystectomyFeasibility StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalOrgan Sparing TreatmentsRetrospective StudiesTreatment OutcomeUreteral NeoplasmsUrinary Bladder NeoplasmsUrologic Surgical Procedures

Identifiers

PMID26797093
PMCPMC4722790
OpenAlexW2268118105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.